Yukio Sugimasa

781 citations
43 papers · 665 indexed · h-index 16

Yukio Sugimasa

40 papers receiving 641 citations

Peers

Yukio Sugimasa
Comparison fields: 5 of 82
  • Hepatology 288
  • Cancer Research 131
  • Oncology 198
  • Epidemiology 218
  • Drug Discovery 1
Replace Shoji Takemiya with:
Shoji Takemiya Japan
Setsuo Tamai Japan
Goro Kajiyama Japan
M Ledermann Switzerland
Andrea Marengo Italy
Kiyokazu Hiwatashi Japan
Yoshinari Takemoto Japan
Yasushi Takii Japan
Kazuho Imanaka Japan
Abdul M. Oseini United States
Yukio Sugimasa relative to Shoji Takemiya Japan Shoji Takemiya's profile →
Citations per field
00.5×1.5×1.8×
Shoji Takemiya · 1×
Citations per year

Countries citing papers authored by Yukio Sugimasa

Since Specialization
Citations

This map shows the geographic impact of Yukio Sugimasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Sugimasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Sugimasa more than expected).

Fields of papers citing papers by Yukio Sugimasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukio Sugimasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Sugimasa. The network helps show where Yukio Sugimasa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yukio Sugimasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yukio Sugimasa Line = papers co-authored together Yukio Sugimasa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20089
2 20079
3 200731
4 20062
5 20060
6 200612
7 200533
8 200515
9 200310
10 20029
11 200238
12 200042
13 19983
14 1997123
15 19951
16 199430
17 199315
18 198931
19
[Clinical effects of Juzendaiho-to on immunologic and fatty metabolic states in postoperative patients with gastrointestinal cancer].
19892
20 19882

About Yukio Sugimasa

Yukio Sugimasa is a scholar working on Hepatology, Gastroenterology and Oncology, having authored 43 papers that have together received 665 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Gastric Cancer Management and Outcomes (9 papers), Colorectal and Anal Carcinomas (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Hepatology (288 citations), Cancer Research (131 citations) and Oncology (198 citations). Yukio Sugimasa has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Makoto Akaike, Shoji Takemiya, Yasushi Rino, Toshio Imada, Kazuo Tarao, Setsuo Tamai, Shinichi Ohkawa, Soichiro Morinaga, Yoshinori Takanashi and Muneki Yoshida. Their work appears in journals such as Journal of Clinical Oncology, Cancer and British journal of surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026